company background image
JNJ logo

Johnson & Johnson SNSE:JNJ Stock Report

Last Price

US$148.27

Market Cap

US$366.3b

7D

0%

1Y

-6.8%

Updated

01 Feb, 2025

Data

Company Financials +

JNJ Stock Overview

Researches, develops, manufactures, and sells various products in the healthcare field worldwide. More details

JNJ fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance4/6
Financial Health4/6
Dividends4/6

Rewards

Risk Analysis

No risks detected for JNJ from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Johnson & Johnson Competitors

Price History & Performance

Summary of share price highs, lows and changes for Johnson & Johnson
Historical stock prices
Current Share PriceUS$148.27
52 Week HighUS$149.19
52 Week LowUS$145.55
Beta0.50
1 Month Change0%
3 Month Change0%
1 Year Change-6.76%
3 Year Change-13.55%
5 Year Change5.32%
Change since IPO63.24%

Recent News & Updates

Recent updates

Shareholder Returns

JNJCL PharmaceuticalsCL Market
7D0%0%0%
1Y-6.8%0%0%

Return vs Industry: JNJ exceeded the CL Pharmaceuticals industry which returned -18.1% over the past year.

Return vs Market: JNJ underperformed the CL Market which returned 13.1% over the past year.

Price Volatility

Is JNJ's price volatile compared to industry and market?
JNJ volatility
JNJ Average Weekly Movement0%
Pharmaceuticals Industry Average Movement0%
Market Average Movement0%
10% most volatile stocks in CL Market0%
10% least volatile stocks in CL Market0%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine JNJ's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1886131,900Joaquin Duatowww.jnj.com

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company’s Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke.

Johnson & Johnson Fundamentals Summary

How do Johnson & Johnson's earnings and revenue compare to its market cap?
JNJ fundamental statistics
Market capUS$366.32b
Earnings (TTM)US$14.07b
Revenue (TTM)US$88.82b

26.0x

P/E Ratio

4.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
JNJ income statement (TTM)
RevenueUS$88.82b
Cost of RevenueUS$27.47b
Gross ProfitUS$61.35b
Other ExpensesUS$47.28b
EarningsUS$14.07b

Last Reported Earnings

Dec 29, 2024

Next Earnings Date

Apr 15, 2025

Earnings per share (EPS)5.84
Gross Margin69.07%
Net Profit Margin15.84%
Debt/Equity Ratio51.0%

How did JNJ perform over the long term?

See historical performance and comparison

Dividends

3.3%

Current Dividend Yield

85%

Payout Ratio

Does JNJ pay a reliable dividends?

See JNJ dividend history and benchmarks
When do you need to buy JNJ by to receive an upcoming dividend?
Johnson & Johnson dividend dates
Ex Dividend DateFeb 18 2025
Dividend Pay DateMar 04 2025
Days until Ex dividend16 days
Days until Dividend pay date30 days

Does JNJ pay a reliable dividends?

See JNJ dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 14:46
End of Day Share Price 2025/01/31 00:00
Earnings2024/12/29
Annual Earnings2024/12/29

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Johnson & Johnson is covered by 56 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Charles ButlerBarclays
Matt MiksicBarclays